EUVIMEDEUVIMED entdecken
Kommentar

A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer

Carmine Settembre

Developmental Cell · 2025

DOI: 10.1016/j.devcel.2025.11.005 ↗

Kurz gefasst

Kommentar in der Zeitschrift Developmental Cell, 2025. Verfasst von Carmine Settembre. Beteiligte Einrichtung: Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, It…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Endoplasmic Reticulum, Proto-Oncogene Proteins p21(ras). Die Arbeit nennt 10 Literaturangaben. Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalEndoplasmic ReticulumProto-Oncogene Proteins p21(ras)AutophagyCell Cycle ProteinsTranscription, GeneticHumans

Substanzen

KRAS protein, humanProto-Oncogene Proteins p21(ras)CCPG1 protein, humanCell Cycle Proteins

Autor:innen und Institutionen

  • Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy. Electronic address: settembre@tigem.it.

Förderung

  • European Research Council

Zitieren

APA

Settembre, C. (2025). A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.11.005

Vancouver

Settembre C. A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.11.005

BibTeX
@article{Settembre2025,
  author = {Settembre, Carmine},
  title = {A matter of selectivity: ER-phagy suppression at the onset of pancreatic cancer},
  journal = {Developmental Cell},
  year = {2025},
  doi = {10.1016/j.devcel.2025.11.005}
}
Kostenlos starten →